"epidermal growth" trang 13 - tải miễn phí từ tailieunhanh
Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: A propensity-matched retrospective study

Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: A propensity-matched retrospective study
10    17    1
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: A retrospective cohort study

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: A retrospective cohort study
14    53    1
A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer

A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer
8    28    1
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
12    27    1
HB-EGF-induced IL-8 secretion from airway epithelium leads to lung fbroblast proliferation and migration

HB-EGF-induced IL-8 secretion from airway epithelium leads to lung fbroblast proliferation and migration
12    43    1
Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M
9    50    1
Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population

Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population
9    56    3
High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine

High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine
13    36    3
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study
7    56    3
The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation

The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation
8    29    1
Gene alternation of cerebrospinal fuid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing

Gene alternation of cerebrospinal fuid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing
8    23    1
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
10    18    1
Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: A systematic review

Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: A systematic review
14    19    1
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer

AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer
13    17    1
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: A phase II, multicenter, single-arm study (SYSUCC-005)

The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: A phase II, multicenter, single-arm study (SYSUCC-005)
8    16    1
Layer-by-layer polysaccharide-coated liposomes for sustained delivery of epidermal growth factor

Layer-by-layer polysaccharide-coated liposomes for sustained delivery of epidermal growth factor
7    17    1
Khảo sát ảnh hưởng của thời gian thiếu máu lạnh lên sự biểu hiện của các dấu ấn ER, PR và HER-2 trong ung thư vú bằng kỹ thuật nhuộm hóa mô miễn dịch

Khảo sát ảnh hưởng của thời gian thiếu máu lạnh lên sự biểu hiện của các dấu ấn ER, PR và HER-2 trong ung thư vú bằng kỹ thuật nhuộm hóa mô miễn dịch
8    32    1
Design, synthesis, and in vitro antitumor activity of 6-aryloxyl substituted quinazoline derivatives

Design, synthesis, and in vitro antitumor activity of 6-aryloxyl substituted quinazoline derivatives
37    9    1
Sex difference in EGFR pathways in mouse kidney-potential impact on the immune system

Sex difference in EGFR pathways in mouse kidney-potential impact on the immune system
13    15    1
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: A systematic review and meta-analysis of 11 randomized controlled trials

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: A systematic review and meta-analysis of 11 randomized controlled trials
14    1    1